Actively Recruiting

Phase Not Applicable
Age: 45Years - 65Years
All Genders
NCT06309563

Metabolic Effects of a Diet Replaced With Essential Amino Acids

Led by Istituto Auxologico Italiano · Updated on 2026-03-31

60

Participants Needed

1

Research Sites

174 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The effectiveness of low-protein diets supplemented with essential aminoacid (EAA) formulas in genetic disorders of amino acid (AA) catabolism, such as maple syrup urine disease (MSUD), is widely recognized (Blackburn PR et al. 2017). The main aim of the present study is to evaluate a difference in the effectiveness of a multidisciplinary rehabilitation program in patients with high degree of obesity with and without supplementation of this new formula of amino acids (essential + tricarboxylic acids - EAA-AC). For this reason, patients of both sexes, aged between 45 and 65, suffering from high-grade obesity will be recruited in Piancavallo. The enrolled patients divided, randomly, into two groups will be given: EAA-AC group a low-calorie and low-protein diet integrated with 4 sachets of EAA-AC supplement per day; the control group will follow a low-calorie and low-protein diet only with placebo. The parameters considered, after two weeks of treatment, will be: weight loss; the maintenance/recovery of muscle mass assessed through changes in body composition and functional tests (Hand grip, 6MWT or TUG) but also through the analysis of mitochondrial function in PBMC and circulating levels of mtDNA; the improvement of the glucose picture and the lipid profile. 1 month after discharge, patients will carry out an outpatient check-up to evaluate the maintenance of muscle mass using impedance testing.

CONDITIONS

Official Title

Metabolic Effects of a Diet Replaced With Essential Amino Acids

Who Can Participate

Age: 45Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Obesity (BMI >35kg/m2)
  • Age 45 to 65 years
  • Both sexes
  • High-grade obesity
Not Eligible

You will not qualify if you...

  • Type 2 diabetes mellitus
  • Renal failure
  • Heart failure (New York Heart Association NYHA, class IV)
  • Liver cirrhosis
  • Neoplasms
  • Muscular or non-autonomic pathologies
  • Neurological-neurodegenerative pathologies
  • Cognitive decline
  • Non-menopausal women
  • Bariatric surgery in the previous 12 months
  • Pharmacological treatment for weight loss in the last three weeks
  • Use of vitamin and amino acid supplements in the last three weeks
  • Hormone therapy (e.g. L-thyroxine, testosterone)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Istituto Auxologico Italiano, Site Piancavallo

Oggebbio, Verbania, Italy, 28921

Actively Recruiting

Loading map...

Research Team

A

Amelia Brunani, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here